Transpulmonary B-Type Natriuretic Peptide Uptake and Cyclic Guanosine Monophosphate Release in Heart Failure and Pulmonary Hypertension. The Effects of Sildenafil

Journal of the American College of Cardiology

Volumn 54, Issue 7, 2009, Pages 595-600

  Melenovsky, Vojtech ^a   Al Hiti, Hikmet ^a   Kazdova, Ludmila ^a   Jabor, Antonin ^a   Syrovatka, Petr ^a   Malek, Ivan ^a   Kettner, Jiri ^a   Kautzner, Josef ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

cGMP; heart failure; pulmonary hypertension; pulmonary vascular resistance; sildenafil

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; NORADRENALIN; PHOSPHODIESTERASE V; PROSTAGLANDIN E1; SILDENAFIL; VASODILATOR AGENT;

ADULT; AGE DISTRIBUTION; ARTERY COMPLIANCE; ARTICLE; BLOOD SAMPLING; BODY SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INHIBITION; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART RATE; HUMAN; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT; PULMONARY ARTERY; PULMONARY ARTERY CATHETER; PULMONARY HYPERTENSION; PULMONARY VEIN; SEX; VASODILATATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASES; 5'-GUANYLIC ACID; ADULT; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PIPERAZINES; PULMONARY ARTERY; PURINES; SULFONES; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 67849092837     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.05.021     Document Type: Article

References (25)

1. Butler J., Chomsky D.B., and Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34 (1999) 1802-1806
2. Lewis G.D., Lachmann J., Camuso J., et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115 (2007) 59-66
3. Guazzi M., Tumminello G., Di Marco F., Fiorentini C., and Guazzi M.D. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44 (2004) 2339-2348
4. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 183-188
5. Di Salvo T.G., Mathier M., Semigran M.J., and Dec G.W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 25 (1995) 1143-1153
6. Moraes D.L., Colucci W.S., and Givertz M.M. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 102 (2000) 1718-1723
7. Cargill R.I., and Lipworth B.J. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects. Chest 110 (1996) 1220-1225
8. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27 (2006) 47-72
9. Forfia P.R., Lee M., Tunin R.S., Mahmud M., Champion H.C., and Kass D.A. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart. J Am Coll Cardiol 49 (2007) 1079-1088
10. Lankhaar J.W., Westerhof N., Faes T.J., et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 29 (2008) 1688-1695
11. Tsutamoto T., Kanamori T., Wada A., and Kinoshita M. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 20 (1992) 541-546
12. Sager G. Cyclic GMP transporters. Neurochem Int 45 (2004) 865-873
13. Kass D.A., Champion H.C., and Beavo J.A. Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 101 (2007) 1084-1095
14. Lewis G.D., Shah R., Shahzad K., et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116 (2007) 1555-1562
15. Lepore J.J., Maroo A., Bigatello L.M., et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 127 (2005) 1647-1653
16. Michaels A.D., Chatterjee K., and De Marco T. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. J Card Fail 11 (2005) 425-431
17. Zimpfer D., Zrunek P., Roethy W., et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 133 (2007) 689-695
18. Levine M.J., Weinstein J.S., Diver D.J., et al. Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation 79 (1989) 1061-1067
19. Mahapatra S., Nishimura R.A., Sorajja P., Cha S., and McGoon M.D. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 47 (2006) 799-803
20. Morris-Thurgood J.A., and Frenneaux M.P. Diastolic ventricular interaction and ventricular diastolic filling. Heart Fail Rev 5 (2000) 307-323
21. Borlaug B.A., Melenovsky V., Marhin T., Fitzgerald P., and Kass D.A. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans. Circulation 112 (2005) 2642-2649
22. Phillips B.G., Kato M., Pesek C.A., et al. Sympathetic activation by sildenafil. Circulation 102 (2000) 3068-3073
23. Al Hesayen A., Floras J.S., and Parker J.D. The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure. Eur J Heart Fail 8 (2006) 864-868
24. Guazzi M., Samaja M., Arena R., Vicenzi M., and Guazzi M.D. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 50 (2007) 2136-2144
25. Murali S., Kormos R.L., Uretsky B.F., et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 126 (1993) 896-904